These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

645 related items for PubMed ID: 29352483

  • 41. Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa.
    McMillan JR, Matsumura T, Hashimoto T, Schumann H, Bruckner-Tuderman L, Shimizu H.
    Exp Dermatol; 2003 Jun; 12(3):261-7. PubMed ID: 12823439
    [Abstract] [Full Text] [Related]

  • 42. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY, Nazaroff J, Iwummadu CV, Harris N, Gorell ES, Fulchand S, Bailey I, McCarthy D, Siprashvili Z, Marinkovich MP, Tang JY, Chiou AS.
    Orphanet J Rare Dis; 2022 Oct 17; 17(1):377. PubMed ID: 36253825
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. A case of epidermolysis bullosa hereditaria--dominant dystrophic type of Cockayne and Touraine.
    Yotsumoto S, Setoyama M, Hisadome H, Tashiro M, Murata F.
    Dermatology; 1993 Oct 17; 186(3):201-4. PubMed ID: 8453148
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Stromal microenvironment in type VII collagen-deficient skin: The ground for squamous cell carcinoma development.
    Guerra L, Odorisio T, Zambruno G, Castiglia D.
    Matrix Biol; 2017 Nov 17; 63():1-10. PubMed ID: 28126522
    [Abstract] [Full Text] [Related]

  • 48. Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.
    Tolar J, Ishida-Yamamoto A, Riddle M, McElmurry RT, Osborn M, Xia L, Lund T, Slattery C, Uitto J, Christiano AM, Wagner JE, Blazar BR.
    Blood; 2009 Jan 29; 113(5):1167-74. PubMed ID: 18955559
    [Abstract] [Full Text] [Related]

  • 49. Targeted Exon Skipping Restores Type VII Collagen Expression and Anchoring Fibril Formation in an In Vivo RDEB Model.
    Turczynski S, Titeux M, Tonasso L, Décha A, Ishida-Yamamoto A, Hovnanian A.
    J Invest Dermatol; 2016 Dec 29; 136(12):2387-2395. PubMed ID: 27498345
    [Abstract] [Full Text] [Related]

  • 50. Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis.
    Schmidt T, Hoch M, Lotfi Jad SS, Solimani F, Di Zenzo G, Marzano AV, Goebeler M, Cozzani E, Kern JS, Sitaru C, Lakoš Jukić I, Sárdy M, Uzun S, Jedlickova H, Gläser R, Kaneda M, Eming R, Göpel G, Ishii N, Greene B, Hashimoto T, Hertl M.
    Br J Dermatol; 2017 Dec 29; 177(6):1683-1692. PubMed ID: 28703393
    [Abstract] [Full Text] [Related]

  • 51. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
    Sitaru AG, Sesarman A, Mihai S, Chiriac MT, Zillikens D, Hultman P, Solbach W, Sitaru C.
    J Immunol; 2010 Feb 01; 184(3):1596-603. PubMed ID: 20038644
    [Abstract] [Full Text] [Related]

  • 52. Type VII collagen is required for Ras-driven human epidermal tumorigenesis.
    Ortiz-Urda S, Garcia J, Green CL, Chen L, Lin Q, Veitch DP, Sakai LY, Lee H, Marinkovich MP, Khavari PA.
    Science; 2005 Mar 18; 307(5716):1773-6. PubMed ID: 15774758
    [Abstract] [Full Text] [Related]

  • 53. Model systems duplicating epidermolysis bullosa acquisita: a methodological review.
    Ludwig RJ.
    Autoimmunity; 2012 Feb 18; 45(1):102-10. PubMed ID: 21923614
    [Abstract] [Full Text] [Related]

  • 54. Response of intractable skin ulcers in recessive dystrophic epidermolysis bullosa patients to an allogeneic cultured dermal substitute.
    Natsuga K, Sawamura D, Goto M, Homma E, Goto-Ohguchi Y, Aoyagi S, Akiyama M, Kuroyanagi Y, Shimizu H.
    Acta Derm Venereol; 2010 Mar 18; 90(2):165-9. PubMed ID: 20169300
    [Abstract] [Full Text] [Related]

  • 55. Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC.
    Martins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M, McGrath JA, Cerio R, Kivisaari A, Kähäri VM, Hodivala-Dilke K, Brennan CH, Chen M, Marshall JF, O'Toole EA.
    J Natl Cancer Inst; 2016 Jan 18; 108(1):. PubMed ID: 26476432
    [Abstract] [Full Text] [Related]

  • 56. Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita.
    Kasprick A, Yu X, Scholten J, Hartmann K, Pas HH, Zillikens D, Ludwig RJ, Petersen F.
    Eur J Immunol; 2015 May 18; 45(5):1462-70. PubMed ID: 25678008
    [Abstract] [Full Text] [Related]

  • 57. Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa.
    Twaroski K, Eide C, Riddle MJ, Xia L, Lees CJ, Chen W, Mathews W, Keene DR, McGrath JA, Tolar J.
    Br J Dermatol; 2019 Dec 18; 181(6):1247-1253. PubMed ID: 30924923
    [Abstract] [Full Text] [Related]

  • 58. Management of epidermolysis bullosa acquisita.
    Intong LR, Murrell DF.
    Dermatol Clin; 2011 Oct 18; 29(4):643-7. PubMed ID: 21925011
    [Abstract] [Full Text] [Related]

  • 59. Familial epidermolysis bullosa acquisita.
    Noe MH, Chen M, Woodley DT, Fairley JA.
    Dermatol Online J; 2008 Dec 15; 14(12):2. PubMed ID: 19265615
    [Abstract] [Full Text] [Related]

  • 60. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens D, Sitaru C.
    J Pathol; 2004 Dec 15; 204(5):519-27. PubMed ID: 15538734
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.